Immatics N.V. Ordinary Shares

IMTXNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
10.72 USD
↘ 0.15 (1.38%)🟢LIVE (AS OF 10:49 AM EDT)
🟢Market: OPEN
Open?$10.87
High?$11.44
Low?$10.66
Prev. Close?$10.87
Volume?74.9K
Avg. Volume?N/A
VWAP?$10.92
Bid / Ask
Bid?$9.12 × 100
Ask?$10.72 × 100
Spread?$1.60
Midpoint?$9.92
Valuation & Ratios
Market Cap?1.5B
Shares Out?134.1M
Float?91.6M
Float %?75.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyHealthcare - Oncology›Cell & Gene Therapy for Cancer
Employees
407
Market Cap
1.5B
Industry
N/A
Website
www.immatics.com
Listed
2020-07-02
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
MarketsMoversWatchlist